-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Cytek Biosciences, Raises Price Target to $5

Benzinga·01/08/2026 18:16:29
Listen to the news
TD Cowen analyst Brendan Smith maintains Cytek Biosciences (NASDAQ:CTKB) with a Buy and raises the price target from $4 to $5.